Direct Methanol Fuel Cell
Press Release
News
 |
Exhibited "Mobile-type Automated GenelyzerTM for Detecting Biological Agents" at GSA(Global Security Asia 2009)
|
||||||||||||||||
|
Exhibited at CEATEC2008
|
||||||||||||||||
|
Exhibited at CEATEC2007
|
||||||||||||||||
| Sep. 25th,2007 | |
Website Renewed |
|||||||||||||||
| Jun. 25th,2007 | |
Exhibited at BIO TECH CHINA2007
|
|||||||||||||||
| June 15th, 2007 | |
Press Release Development of a high reliable DNA chip for molecular diagnotics Daiichi Pure Chemicals Co., Ltd., has applied for approval to
manufacture and sell in vitro medical diagnostic agents that employs
DNA chips to determine genotype of human papillomavirus, that it
co-developed with Toshiba Corporation and Toshiba Hokuto Electronics
Corporation. |
|||||||||||||||
| Jul. 11th, 2006 | |
Press Release Daiichi Pure Chemicals, Toshiba and Toshiba Hokuto Electronics agree to co-develop and commercialize in vitro diagnostic agents employing electrochemical DNA chips. The three companies, Daiichi Pure Chemicals Co., Ltd. (Daiichi Chemicals) Toshiba Corp. (Toshiba) and Toshiba Hokuto Electronics Corp. (Toshiba Hokuto Electronics), have agreed to co-develop and commercialize in vitro diagnostic agents employing DNA chips that combine electrochemical DNA chips developed by Toshiba and Daiichi Chemical's know how of in vitro diagnostic agents, and concluded a Basic Agreement on the Co-development and Commercialization of DNA Chips. |
|||||||||||||||
|
Press Release Development of DNA chips incorporating semiconductor circuit technology
A DNA chip that realizes both high detection sensitivity and miniaturization has been developed using CMOS (complementary type metallic oxide semiconductor) integrated circuit technology that is widely used in semiconductors. This, together with chips previously developed by Toshiba to assess communicable diseases and the side-effects of drugs, will facilitate development of chips capable of handling new test categories such as monitoring of the onset and progression of cancer and other serious diseases. |
||||||||||||||||
| Sep. 21st, 2004 | |
Press Release Toshiba Corporation and Tokyo Women's Medical University co-develop a DNA chip for rheumatism treatment
Toshiba Corporation and a group headed by Prof. Naoyuki Kamatani of Tokyo Women's Medical University (Institute of Rheumatology) have co-developed a DNA chip capable of assessing drug efficacy and side effects and the probability of complications occurring in individual patients undergoing treatment for rheumatism from differences in genetic information unique to each patient.Verification of the chip's effectiveness will be conducted at the Institute of Rheumatology, Tokyo Women's Medical University from October towards its practical application. |
|||||||||||||||
| Aug. 23rd, 2004 | |
Exhibited at BioJapan2004 Exhibition
Symposium
|
|||||||||||||||
| Jul. 27th, 2004 | |
Press Release Toshiba Corp. and Prof. Azuma of Osaka University commence joint development of a DNA chip to assess drug susceptibility and side-effects Together with a group headed by Prof. Junichi Azuma of Osaka University (Graduate School of Pharmaceutical Sciences), Toshiba has commenced development of a DNA chip capable of assessing drug efficacy and side-effects for individual patients from differences in each patient's genetic information (a DNA chip that predicts drug disposition). |
|||||||||||||||
| Mar. 30th, 2004 | |
Site Renewed |
|||||||||||||||
| Jun. 22nd, 2003 | |
Exhibited at BIO2003 "BIO 2003 Annual Convention"
|
|||||||||||||||
| Jun. 20th, 2003 | |
Press Release Development of an automatic DNA testing device GenelyzerTM »Click here for details |
|||||||||||||||
| Jun. 20th, 2003 | Site Renewed |
||||||||||||||||
| Jun. 19th, 2003 | |
Press Release Conclusion of an agreement with the Institute of Human Virology (IVH) in the U.S. to engage in joint research related to personalized treatments for AIDS »Click here for details |
|||||||||||||||
